<<2022년 제37차 학술대회>>
|
| 08:30-08:50 | Registration | 이대우 (대한부인종양학회 사무총장) |
| Convention hall | ||
|---|---|---|
| 08:50-09:00 | 개회사 및 명예회원증 수여 | 김영태 (대한부인종양학회 회장) |
| Session I-1 Keynote Lecture I | 좌장: 유희석 (아주의대) 김영탁 (울산의대) | |
| 09:00-09:25 | Recurrent ovarian cancer: when does surgery make a difference?  |
Ginger J. Gardner (Memorial Sloan Kettering Cancer Center, USA) |
| Designated discussion | 임가원 (동국의대) | |
| 09:25-09:50 | Overcoming homologous recombination proffciency in ovarian cancer |
Aikou Okamoto (Jikei University, Japan) |
| Designated discussion | 최윤진 (가톨릭의대) | |
| Session I-2 Keynote Lecture II | 좌장: 김재원 (서울의대) 이철민 (차의대) | |
| 09:50-10:15 | Recent progress of precision medicine in ovarian cancer |
Andreas du Bois (Kliniken Essen-Mitte, Germany |
| Designated discussion | 박수진 (서울의대) | |
| 10:15-10:40 | Bio- and GenomeBank Denmark (RBGB) including the danish cancerbiobank |
Estrid Hoegdall (University of Copenhagen, Denmark) |
| Designated discussion | 유상영 (원자력병원) | |
| 10:40-11:00 | Coffee break | |
| Session II-1 Plenary session I | 좌장: 김승철 (이화의대) 조치흠 (계명의대) | |
| 11:00-11:10 | Lymphadenectomy in clinically early epitheLial ovarian cancer and survival analysis: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion (GORILLA) group (GORILLA-3002)  |
양은정 (건국의대) |
| 11:10-11:20 | Optimum selection criteria for secondary cytoreductive surgery in patients with recurrent ovarian cancer: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion (GORILLA) group (GORILLA-3001)) |
손주혁 (아주의대) |
| 11:20-11:30 | Selection Criteria for Omitting interval debulking suRgery after nEoadjuvant chemotherapy for advanced high-grade serous carcinoma of the ovary: KGOG OVsurg-2016/SCORE study |
박수진 (서울의대) |
| 11:30-11:40 | Designated discussion | 조한별 (연세의대) 이대형 (영남의대) 이원무 (한양의대) |
| Session II-2 Plenary session II | 좌장: 배덕수 (을지의대) 최중섭 (한양의대) | |
| 11:40-11:50 | A nomogram to predict anastomotic leakage after resection of the rectosigmoid colon in primary ovarian cancer | 김지현 (국립암센터) |
| 11:50-12:00 | Optimal management of platinum-sensitive relapsed ovarian clear cell carcinoma: A multi-center study in Korea | 김세익 (서울의대) |
| 12:00-12:10 | Prognostic impact of erythropoietin-stimulating agents during front-line chemotherapy in patients with ovarian cancer: A Korea multicenter cohort study |
심승혁 (건국의대) |
| 12:10-12:20 | Designated discussion | 이선주 (건국의대) 신진우 (가천의대) 남은지 (연세의대) |
| Luncheon symposium | 좌장: 남주현 (울산의대) 김용범 (서울의대) | |
| 12:20-12:40 | A new powder-type hemostatic agent in gynecologic oncologic surgical procedures |
박성택 (한림의대) |
| 12:40-13:00 | The incorporation of HPV testing for cervical cancer screening: The What, Why, and How? |
Warner K. Huh (University of Alabama at Birmingham, USA) |
| 13:00-13:30 | Lunch | |
| Symposium I- Convention hall | ||
| Session Ⅲ-1 Focused plenary session Ⅰ | 좌장: 김재욱 (연세의대) 남궁성은 (가톨릭의대) | |
| 13:30-13:40 | Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer | 김기동 (서울의대) |
| 13:40-13:50 | Ten-year survival for patients with epithelial ovarian cancer treated with consolidation hyperthermic intraperitoneal chemotherapy |
유지근 (가톨릭의대) |
| 13:50-14:00 | Genome-based molecular classification and clinicopathological features in korean patients |
한경희 (차의대) |
| 14:00-14:10 | Anticancer effect of fenbendazole according to drug delivery mode in ovarian cancer models | 장지선 (성균관의대) |
| 14:10-14:20 | Open versus minimally invasive radical hysterectomy in early-stage cervical cancer with usual type adenocarcinoma and adenosquamous carcinoma: A two-center retrospective study with central pathology review |
김여래 (서울의대) |
| Session Ⅲ-2 Focused plenary session Ⅱ | 좌장: 강순범 (서울의대) 허수영 (가톨릭의대) | |
| 14:20-14:30 | Development and validation of a prediction model for successful complete cytoreduction at primary cytoreductive surgery for advanced ovarian cancer by integrating of 18F-FDG PET/CT parameters and CA-125 | 김준환 (서울의대) |
| 14:30-14:40 | Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer | 전정은 (성균관의대) |
| 14:40-14:50 | Evaluation of anti-cancer e cacy of siRNA targeting HPV16 E6 and E7 combined with cisplatin in cervical cancer cells xenograft mouse model | 박민정 (울산의대) |
| 14:50-15:00 | Plasma-activated medium inhibits cancer stem cell-like properties and exhibits a synergistic effect in combination with cisplatin in ovarian cancer | 권병수 (경희의대) |
| 15:00-15:10 | Anti-cancer activity of cabozatinib and temozolomide and their e cacy for uterine leiomyosarcoma in a mouse xenograft mode | 노준호 (성균관의대) |
| 15:10-15:30 | Coffee break | |
| Session Ⅳ 부인암 수술동의서 개발 및 HPV 연구용역사업 보고 | 좌장: 이종민 (경희의대) 이재관 (고려의대) | |
| 15:30-15:45 | 의사의 설명의무와 의료분쟁 |
현두륜 변호사 (법무법인 세승) |
| 15:45-15:55 | 수술동의서 소개 |
심승혁 (건국의대) |
| 15:55-16:05 | Discussion | 장하균 (고려의대) |
| 16:05-16:20 | 국가암검진 자궁경부암 선별검사에서 인유두종바이러스 DNA검사의 비용-효과 분석 |
김현규 (연세의대 예방의학교실) |
| 16:20-16:30 | Discussion | 정대훈 (인제의대) |
| Symposium II- Crystal hall 1 | ||
| Session Ⅲ-3 Focused plenary session Ⅲ | 좌장: 김병기 (성균관의대) 성석주 (차의대) | |
| 13:30-13:40 | Effect of post-operative hormone replacement therapy on survival in women with ovarian cancer | 이방현 (인하의대) |
| 13:40-13:50 | Efficacy and potential pitfalls of pre-operative PET-CT in endometrial cancer patients undergoing one-step and two-step sentinel lymph node mapping: Is PET-CT negative really node negative? |
김유나 (연세의대) |
| 13:50-14:00 | Survival outcomes from laparoscopic radical hysterectomy in conizationskipped, stage IB1 cervical cancer | 임현지 (서울의대) |
| 14:00-14:10 | Role of glycine decarboxylase in chemo-resistant ovarian cancer cells | 이승미 (계명의대) |
| 14:10-14:20 | Is minimally invasive surgery safe for cervical cancer patients with a diameter of less than 2 cm? | 공태욱 (아주의대) |
| Session Ⅲ-4 Focused plenary session Ⅳ | 좌장: 김용만 (울산의대) 김태진 (건국의대) | |
| 14:20-14:30 | Incidence of cervical intraepithelial neoplasia in republic of korea: A nationwide cross-sectional study 2009-2018 | 경민선 (한림의대) |
| 14:30-14:40 | A phase II trial of docetaxel/cisplatin chemotherapy followed by pelvic radiation therapy in patients with high-risk endometrial carcinoma after staging surgery | 조윤정 (울산의대) |
| 14:40-14:50 | Role of klotho as a modulator of oxidative stress associated with ovarian tissue cryopreservation | 이상훈 (고려의대) |
| 14:50-15:00 | Comparison of outcome of sentinel node biopsy vs. Lymphadenectomy in endometrial cancer: A propensity-matched data | 이다혜 (연세의대) |
| 15:00-15:10 | Enhanced susceptibility to cervical cancer in korean women with elevated serum gamma-glutamyltransferase levels: A nationwide population-based cohort study |
설애란 (고려의대) |
| 15:10-15:30 | Coffee break | |
| Session Ⅴ Biomarkers and application in precision medicine for gynecologic cancers | 좌장: 유종우 (국립암센터 병리학교실) 박노현 (서울의대) 김재훈 (연세의대) | |
| 15:30-15:50 | Biomarkers for molecular classification of endometrial cancer |
김현수 (성균관의대 병리학교실) |
| 15:50-16:10 | Biomarkers and HRD for ovarian cancer |
김효진 (서울의대 병리학교실) |
| 16:10-16:30 | Biomarkers for uterine sarcoma and rare tumors |
조화진 (인제의대 병리학교실) |
| Symposium Ⅲ- Crystal hall 2 | ||
| Session Ⅲ-5 Focused plenary session Ⅴ | 좌장: 남계현 (순천향의대) 장석준 (아주의대) | |
| 13:30-13:40 | Prediction of platinum-based chemotherapy sensitivity for epithelial ovarian cancer by magnetic resonance-based radiomics | 송희경 (가톨릭의대) |
| 13:40-13:50 | Trends in incidence and survival of patients with vulvar cancer in an asian country: analysis of the korean central cancer registry 1999–2018 | 조성실 (한양의대) |
| 13:50-14:00 | Recurrence prediction of endometrial cancer patients with various machine learning technique |
신원교 (충남의대) |
| 14:00-14:10 | Anti-tumor effects of lenvatinib plus anti-PD-1 in syngeneic murine cervical cancer models | 강지식 (울산의대) |
| 14:10-14:20 | The expression of HOXA-AS3 induces tumor progression through the epithelialmesenchymal transition pathway in epithelial ovarian cancer | 어경진 (연세의대) |
| Session Ⅲ-6 Focused plenary session Ⅵ | 좌장: 김기형 (부산의대) 박철민 (제주의대) | |
| 14:20-14:30 | Clinical characteristics and desensitization protocol of chemotherapy-induced hypersensitivity reactions in patients with gynecologic cancer | 김승호 (울산의대) |
| 14:30-14:40 | Impact of neoadjuvant chemotherapy cycles in patients with advanced epithelial ovarian cancer: meta-analysis and systemic review | 조현웅 (고려의대) |
| 14:40-14:50 | Identification of immune-related biomarkers associated with BRCA mutations in epithelial ovarian cancer | 김효선 (연세의대) |
| 14:50-15:00 | Lymphedema in cervical cancer survivor: a nationwide cohort study | 이수정 (가톨릭의대) |
| 15:00-15:10 | Multiplexed immunohistochemistry for immune profiling in cervical cancer according to tumor budding status |
김종미 (경북의대) |
| 15:10-15:30 | Coffee break | |
| Session Ⅲ-7 Focused plenary session VII | 좌장: 이정원 (성균관의대) 김상운 (연세의대) | |
| 15:30-15:40 | DKK3, downregulated in ovarian cancer, enhanced paclitaxel susceptibility by inhibiting the P-glycoprotein | 이은주 (중앙의대) |
| 15:40-15:50 | Effect of quality control program in surgical management of early cervical cancer | 김보라 (이화의대) |
| 15:50-16:00 | CD8α+ dendritic cells enhance the antitumor and immune activities against syngeneic and orthotopic murine ovarian cancer models | 남소현 (울산의대) |
| 16:00-16:10 | Robotic single-site radical hysterectomy for early cervical cancer: A single center experience of 5 years | 장태규 (계명의대) |
| 16:10-16:20 | Prediction of lymphovascular space invasion in patients with endometrial cancer | 김상일 (가톨릭의대) |
| 16:20-16:30 | Neutrophil–lymphocyte and platelet–lymphocyte ratios in preoperative differential diagnosis of benign, borderline, and malignant ovarian tumors |
유정민 (대구가톨릭의대) |
| Convention hall | ||
| Session Ⅵ Tumor board | 좌장: 김대연 (울산의대) 이택상 (서울의대) | |
| 16:40-17:20 | Endometrial cancer with suspicious lymph node metastasis |
박정열 (울산의대) |
| Panel discussion | 김태훈 (서울의대) 이유영 (성균관의대) 김미경 (이화의대) | |
| 17:20 | 폐회사 | 김영태 (대한부인종양학회 회장) |
| 18:30 | 신풍호월학술상 & JGO Best Paper & Reviewer Award 시상 및 만찬 | |
제26차 대한부인종양학회 추계심포지엄 E-Conference
|
| 통합 Program | ||
|---|---|---|
| 사회: 서동훈 (대한부인종양학회 사무총장) | ||
| 08:30-08:40 | Opening Remarks | 김승철 (대한부인종양학회 회장) |
| Session I-1제4회 부인종양의학상 시상식 및 발표 | 좌장: 배덕수 (성균관의대) 김영탁 (울산의대) |
|
| 08:40-08:50 | 부인종양의학상 학술대상 수상자 논문 발표 |
|
| 08:50-09:00 | 부인종양의학상 젊은의학자상 수상자 논문 발표 |
|
| Session I-2The Best Real-World Practice | 좌장: 김영태 (연세의대) 김재원 (서울의대) |
|
| 09:00-09:20 | The best type of PARPi for the best time in the management of ovarian cancer
|
이신화 (울산의대) |
| 09:20-09:40 | The best type of PD1 inhibitor for the best time in the management of cervical cancer
|
이원무 (한양의대) |
| 09:40-10:00 | PD1 inhibitor with/without multiple kinase inhibitor for the treatment of endometrial cancer
|
이유영 (성균관의대) |
| 10:00-10:20 | Which phase II/III RCTs in ovarian cancer will be finalized in 5 year?
|
유헌종 (충남의대) |
| 10:20-10:30 | Discussion | |
| Session I-3Clinical Studies Update in Gynecologic Cancer | 좌장: 남계현 (순천향의대) 이종민 (경희의대) |
|
| 10:30-10:50 | Secondary cytoreductive surgery in recurrent epithelial ovarian cancer
|
이산희 (연세원주의대) |
| 10:50-11:10 | Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer | 임명철 (국립암센터) |
| 11:10-11:30 | ADC(Antibody-Drug Conjugate) in management of ovarian cancer |
조한별 (연세의대) |
| 11:30-11:50 | Novel discoveries in endometrial cancer: are we making progress?
|
이성종 (가톨릭의대) |
| 11:50-12:10 | Screening for lynch syndrome in endometrial cancer patients
|
김미경 (이화의대) |
| 12:10-12:20 | Discussion | |
| Luncheon Symposium | 좌장: 김기형 (부산의대) | |
| 12:20-12:40 | Rationale for earlier intervention with PARP inhibitor and importance of personalized medicine in ovarian cancer
|
김기동 (서울의대) |
| 12:40-13:40 | Lunch | |
| 학술 Program | ||
|---|---|---|
| 사회: 서동훈 (대한부인종양학회 사무총장) | ||
| Session II-1International Issues | ||
| 13:40-14:00 | Quality control of surgery in advanced epithelial ovarian cancer
|
좌장: 장석준 (아주의대) |
| Christina Fotopoulou (Imperial College London, UK) |
||
| 14:00-14:05 | Discussion | 김희승 (서울의대) |
| 14:05-14:25 | Current and future considerations for the use of checkpoint inhibitors in gynecologic cancers
|
좌장: 강석범 (국립암센터) |
| David O'Malley (The Ohio State University, USA) |
||
| 14:25-14:30 | Discussion | 어경진 (연세의대) |
| 14:30-14:45 | An introduction to NUWA-National gynecological oncology research and
patient management platform
|
좌장: 이택상(서울의대) |
| Qinglei Gao (Huazhong University, China) |
||
| 14:45-14:50 | Discussion | 김세익 (서울의대) |
| Session II-2Special Lectures | 좌장: 허수영 (가톨릭의대) 이재관 (고려의대) |
|
| 14:50-15:10 | 9가 자궁경부암 예방백신 허가 사항 - 진료권고안 업데이트
|
민경진 (고려의대) |
| 15:10-15:30 | Future treatment strategy based on PARPi frontline ovaian cancer
|
Antonio González-MartÍn (ClÍnica Universidad de Navarra, Spain) |
| 15:30-15:50 | Patient blood management as a standard of care
|
이정재 (순천향의대) |
| 15:50-16:00 | Perioperative use of IV iron in gynecologic cancer patients (증례발표)
|
서동훈 (서울의대) |
| 16:00-16:30 | Clinical impact of febrile neutropenia with ovarian cancer by pegfilgrastim
|
최철훈 (성균관의대) |
| 16:30-16:40 | Discussion | |
| 16:40 | Closing Remarks | |
| 16:50-17:10 | 정기총회(ZOOM Meeting) | |
| 간호분과 Program | ||
|---|---|---|
| 사회: 문혜성 (이대목동병원) | ||
| 13:30-13:40 | Opening Remarks | 노주희 (대한부인종양학회 간호분과소위원장) |
| Nursing Session I-1Key Updates in Hereditary Gynecologic Cancer | 좌장: 노주희 (전북대학교 간호대학) 이정원 (성균관의대) |
|
| 13:40-14:00 | Recent clinical trial outcome based on the hereditary predisposition of gynecologic cancer | 신소진 (계명의대) |
| 14:00-14:20 | Clinical significance and reclassification of PV/LPV/VUS of BRCA 1/2 | 남은지 (연세의대) |
| 14:20-14:40 | What should we know about real-world genetic counseling of hereditary gynecologic
cancer? |
정고운 (국립암센터) |
| 14:40-14:50 | Discussion | |
| Nursing Session I-2New Trend in Genetic Care in Gynecologic Oncology | 좌장: 노기옥 (건양대학교 간호대학) 김태진 (건국의대) |
|
| 14:50-15:10 | Genome & health record
|
홍경원 (테라젠이텍스) |
| 15:10-15:30 | New treatment for hereditary gynecologic cancer
|
유선영 (서울아산병원) |
| 15:30-15:50 | Knowledge and anxiety in hereditary ovarian cancer patients
|
이상희 (국립암센터) |
| 15:50-16:00 | Discussion | |
강의록 다운로드